Short-term effects of growth hormone treatment on the upper airways of non severely obese children with Prader-Willi syndrome
Authors:
- 15 May 2009
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 32 (7) , 601-605
Abstract
Aims: The aim of this study was to establish whether short-term GH treatment causes obstructive apnea in patients with Prader-Willi syndrome and normal upper airway patency. Subjects and methods: We performed an observational longitudinal 6-week GH treatment study. Thirtyfour non-severely obese Prader-Willi syndrome patients (20 boys, age range 0.94–11.8 yr, median 2.24 yr) entered an observational longitudinal 6-week study. Sixteen boys received recombinant human GH (rhGH) treatment; the remaining 18 represented the control group and received no treatment. Polysomnography monitoring and othorhino-laringoiatric video endoscopy were performed one night before and after 6 weeks of rhGH treatment (0.03 mg/kg body weight/day). All patients underwent auxologic assessment, fasting blood glucose, insulin and IGF-I evaluation. The main polysomnographic parameter considered was total apnea hypopnea index, consisting of two components: central apnea hypopnea index and obstructive apnea hypopnea index. All patients were free of severe or moderate upper airway obstruction when rhGH treatment began. Results: After 6 weeks of rhGH therapy, obstructive apnea hypopnea index increased in 8/16 (50%), decreased in 5/16 (31%), and did not change in 3/16 (19%) patients. The changes were not statistically significant. The rhGH-treated group did not differ from the control group for the apnea hypopnea index both before and after 6 weeks of treatment. Adenoids and tonsils showed a slight increase in 1 and 2 patients on rhGH treatment, respectively, and did not change in the untreated patients. Conclusions: Our data show that short-term rhGH treatment does not cause restrictions of the upper airways in patients with Prader-Willi syndrome and normal upper airway patency.Keywords
This publication has 32 references indexed in Scilit:
- Prader-Willi syndrome: who can have growth hormone?Archives of Disease in Childhood, 2008
- The Italian National Survey for Prader–Willi syndrome: An epidemiologic studyAmerican Journal of Medical Genetics Part A, 2008
- Development of a WHO growth reference for school-aged children and adolescents2007
- Reference values for sleep‐related respiratory variables in asymptomatic European children and adolescentsPediatric Pulmonology, 2006
- Death in two female Prader‐Willi syndrome patients during the early phase of growth hormone treatmentActa Paediatrica, 2005
- Deaths in Children with Prader-Willi SyndromeHormone Research in Paediatrics, 2005
- Sudden Death in Prader-Willi Syndrome during Growth Hormone TherapyHormone Research in Paediatrics, 2005
- Sudden death in growth hormone–treated children with Prader-Willi syndromeThe Journal of Pediatrics, 2004
- In Vivo Effects of Growth Hormone on Thymic CellsAnnals of the New York Academy of Sciences, 2003
- Fatal Outcome of Sleep Apnoea in PWS during the Initial Phase of Growth Hormone TreatmentHormone Research in Paediatrics, 2002